European Drug Safety Summit 2018
In-Person Event
Mar 07 - 08, 2018
London, England, GB
OVERVIEW
European Drug Safety Summit is organized by Active Communications International (ACI) and will be held during Mar 07 - 08, 2018 at London, England, United Kingdom.
The target audience for this medical event is pharmaceutical, biotechnology and contract research organizations and include VPs, Directors and Managers/Scientists working in Drug Safety, Pharmacovigilance, Epidemiology, Clinical Research and Development, Clinical Trial Management, Pharmacology, Regulatory Affairs and Compliance, Strategy and Business Development, Risk Management, QPPV.
Conference Description :
The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies, will discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulatory requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.
Conference Key Topics :
• Meeting Safety Requirement: Regulator’s Perspective
• Building a Pharmacovigilance Strategy
• Evolving PV Strategies for Tomorrow
• Technological Advancement in Pharmacovigilance
• Clinical Data Management
• The Role of Big Data and Social Media in PV
• Ensure Drug Safety & Risk Minimisation Measures
• Latest Development & Innovation Approach for Effective Signal Management
• Development of Qualified Personal Responsible for Pharmacovigilance (QPPV)
• Pharmacovigilance for Advanced Therapies
Additional details will be posted as soon as they are available.
The target audience for this medical event is pharmaceutical, biotechnology and contract research organizations and include VPs, Directors and Managers/Scientists working in Drug Safety, Pharmacovigilance, Epidemiology, Clinical Research and Development, Clinical Trial Management, Pharmacology, Regulatory Affairs and Compliance, Strategy and Business Development, Risk Management, QPPV.
Conference Description :
The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies, will discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulatory requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.
Conference Key Topics :
• Meeting Safety Requirement: Regulator’s Perspective
• Building a Pharmacovigilance Strategy
• Evolving PV Strategies for Tomorrow
• Technological Advancement in Pharmacovigilance
• Clinical Data Management
• The Role of Big Data and Social Media in PV
• Ensure Drug Safety & Risk Minimisation Measures
• Latest Development & Innovation Approach for Effective Signal Management
• Development of Qualified Personal Responsible for Pharmacovigilance (QPPV)
• Pharmacovigilance for Advanced Therapies
Additional details will be posted as soon as they are available.
KEY DATES
07 Mar, 2018
Event Start Date
08 Mar, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineResearch and Clinical ResearchSUGGESTED HOTELS
CONFERENCE VENUE
TBDRELATED CONFERENCES & LIVE WEBINARS
Quick Links